Long Term Investment, Biotech & High Yield Dividend Stocks

[peewee]

Antisoma to present at 9th Annual Needham Life Sciences Conference and 4th Annual Jefferies Healthcare Conference in New York
Date : 06/04/2010 @ 7:00AM
Source : UK Regulatory (RNS & others)
Stock : Antisoma (ASM)
Quote : 7.3 1.2 (19.67%) @ 7:13AM


Antisoma to present at 9th Annual Needham Life Sciences Conference and 4th Annual Jefferies Healthcare Conference in New York

TIDMASM

04 June 2010, London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC:
ATSMY) announces that Daniel Elger, VP Marketing & Communications, will present
at the 9th Annual Needham Life Sciences Conference in New York at 09.20 am local
time (2.20 pm BST) on Thursday 10 June and the 4th Annual Jefferies Healthcare
Conference in New York at 12.45 pm local time (5.45 pm BST) on Friday 11 June.

A webcast of the presentation at the Needham conference will be available on
Antisoma's website athttp://www.antisoma.com/asm/media/webcast/

For live viewing of the webcast, it is recommended that viewers log on 15
minutes early in order to register and download any necessary software.

Enquiries:
Alison Saville
Senior Marketing and Communications Executive
Antisoma plc
[phone]

Background on Antisoma
Antisoma is a London Stock Exchange-listed biopharmaceutical company that
develops novel products for the treatment of cancer. The Company has operations
in the UK and the US. Please visitwww.antisoma.com <http://www.antisoma.com>; for
further information about Antisoma.